HNRNPA2B1 and neoplasm: In contrast to the cancer research findings, knockout of HNRNPA2B1 by CRISPR/CAS9 method promotes the TNBC cell migration and invasion but alleviates tumor growth by activating the ERK-MAPK/Twist and GR-beta/TCF4 signaling pathways.